ArthroCare Receives FDA Clearance for Parallax Contour-Enhanced Vertebral Augmentation Device

ArthroCare, a maker of minimally invasive surgical products, has received FDA clearance for its second-generation Parallax Contour-enhanced vertebral augmentation device, according to a news release.

Advertisement

The device is specifically for void creation in a vertebral body, followed by injection of bone cement. Vertebral augmentation, also known as vertebroplasty or kyphoplasty, is commonly used to treat painful vertebral compression fractures. This second-generation device allows surgeons to operate in tight spaces and to provide additional tactile and audible feedback to improve ease of use during the void creation process.

Read the news release about ArthroCare’s Parallax Contour-enhanced vertebral augmentation device.

Read other coverage about ArthroCare.

ArthroCare Total Revenue Increases by 10.6% to $87.9M

ArthroCare Receives FDA 510(k) Clearance for Suture Implant System

ArthroCare Corp. Announces More Than 4 Percent Increase in 2009

http://insurancenewsnet.com/article.aspx?id=248951

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Since March 25, there have been two key developments in lawsuits involving spine medtech companies. 1. The U.S. Court of…

  • The highest-paid CFOs at spine and orthopedic medtech companies saw total compensation reaching in the mid-single digits and beyond. Here…

Advertisement

Comments are closed.